There is limited evidence to guide successful treatment of recurrent Campylobacter infection in patients with common variable immunodeficiency (CVID) already managed on regular immunoglobulin therapy. The role of faecal microbiota transplant (FMT) is uncertain. We report a case of recurrent Campylobacter jejuni infection in a patient with CVID treated with repeated FMT with 18 months of symptom resolution prior to relapse.
Original languageEnglish
Pages (from-to)56-62
Number of pages7
JournalInfectious Disease Reports
Issue number1
Early online date12 Jan 2022
Publication statusPublished - Feb 2022


  • Campylobacter jejuni
  • faecal microbiota transplant
  • common variable immunodeficiency
  • microbiota


Dive into the research topics of 'Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report'. Together they form a unique fingerprint.

Cite this